Weihui Lu

519 total citations
35 papers, 362 citations indexed

About

Weihui Lu is a scholar working on Complementary and alternative medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Weihui Lu has authored 35 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Complementary and alternative medicine, 13 papers in Cardiology and Cardiovascular Medicine and 11 papers in Molecular Biology. Recurrent topics in Weihui Lu's work include Cardiovascular and exercise physiology (8 papers), Cardiovascular Function and Risk Factors (5 papers) and Heart Rate Variability and Autonomic Control (5 papers). Weihui Lu is often cited by papers focused on Cardiovascular and exercise physiology (8 papers), Cardiovascular Function and Risk Factors (5 papers) and Heart Rate Variability and Autonomic Control (5 papers). Weihui Lu collaborates with scholars based in China, Sweden and United States. Weihui Lu's co-authors include Yuchao Chen, Zhenhua Dai, Qunfang Zhang, Feifei Qiu, Huazhen Liu, Xiankun Chen, Wei Jiang, Zehuai Wen, Cecilia Stålsby Lundborg and Gaetano Marrone and has published in prestigious journals such as Frontiers in Immunology, Biochemical Pharmacology and Ecotoxicology and Environmental Safety.

In The Last Decade

Weihui Lu

28 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weihui Lu China 11 112 87 75 63 63 35 362
Chen Xia China 9 47 0.4× 103 1.2× 25 0.3× 53 0.8× 23 0.4× 23 328
Hui Yi China 9 45 0.4× 81 0.9× 35 0.5× 27 0.4× 25 0.4× 14 357
Takahiro Shirasawa Japan 9 73 0.7× 77 0.9× 38 0.5× 77 1.2× 14 0.2× 10 333
Yun‐Hong Cheon South Korea 11 93 0.8× 143 1.6× 48 0.6× 16 0.3× 13 0.2× 48 456
Ewelina Józefczuk Poland 8 68 0.6× 198 2.3× 47 0.6× 71 1.1× 10 0.2× 12 412
Xueqing Li China 12 41 0.4× 136 1.6× 52 0.7× 19 0.3× 18 0.3× 48 333
Cleverson Rodrigues Fernandes Brazil 10 79 0.7× 70 0.8× 36 0.5× 32 0.5× 7 0.1× 29 325
Layla Al-Mansoori Qatar 10 36 0.3× 147 1.7× 42 0.6× 33 0.5× 11 0.2× 30 392
Min Cheng China 13 37 0.3× 102 1.2× 42 0.6× 101 1.6× 10 0.2× 31 380

Countries citing papers authored by Weihui Lu

Since Specialization
Citations

This map shows the geographic impact of Weihui Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihui Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihui Lu more than expected).

Fields of papers citing papers by Weihui Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihui Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihui Lu. The network helps show where Weihui Lu may publish in the future.

Co-authorship network of co-authors of Weihui Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Weihui Lu. A scholar is included among the top collaborators of Weihui Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihui Lu. Weihui Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yuchao, Huazhen Liu, Yuming He, et al.. (2025). Roles for Exosomes in the Pathogenesis, Drug Delivery and Therapy of Psoriasis. Pharmaceutics. 17(1). 51–51. 4 indexed citations
2.
Qiu, Feifei, et al.. (2025). The immunoregulatory effects of scoparone on immune-mediated inflammatory diseases. Frontiers in Immunology. 16. 1518886–1518886.
3.
4.
Chen, Xiankun, et al.. (2024). Establishing a Novel Model to Assess Exercise Capacity in Chronic Heart Failure Based on Stress Echocardiography. ESC Heart Failure. 11(6). 4335–4347. 2 indexed citations
5.
6.
Chen, Yuchao, et al.. (2024). The TOPK Inhibitor HI-TOPK-032 Enhances CAR T-cell Therapy of Hepatocellular Carcinoma by Upregulating Memory T Cells. Cancer Immunology Research. 12(5). 631–643. 7 indexed citations
7.
Lin, Hong, Wenjing Xu, Tao-Hua Lan, et al.. (2024). The association between frailty and the risk of mortality in critically ill congestive heart failure patients: findings from the MIMIC-IV database. Frontiers in Endocrinology. 15. 1424257–1424257. 1 indexed citations
8.
Lan, Tao-Hua, Yunshan Wu, Lin Jiao, et al.. (2024). Integrating Network Pharmacology and Experimental Validation to Investigate the Mechanism of Qushi Huatan Decoction Against Coronary Heart Disease. Drug Design Development and Therapy. Volume 18. 4033–4049. 2 indexed citations
9.
Liu, Tong, Wei Jiang, Wenjing Xu, et al.. (2023). Xin-Li-Fang efficacy and safety for patients with chronic heart failure: A study protocol for a randomized, double-blind, and placebo-controlled trial. Frontiers in Cardiovascular Medicine. 10. 1103548–1103548.
10.
Zhu, Ying, et al.. (2023). Xin-Li formula attenuates heart failure induced by a combination of hyperlipidemia and myocardial infarction in rats via Treg immunomodulation and NLRP3 inflammasome inhibition. Journal of Traditional and Complementary Medicine. 13(5). 441–453. 7 indexed citations
11.
Zheng, Fang, Qunfang Zhang, Chun-Ling Liang, et al.. (2023). Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis. Frontiers in Pharmacology. 14. 1145407–1145407. 29 indexed citations
12.
Chen, Xiankun, et al.. (2023). Left atrial dysfunction can independently predict exercise capacity in patients with chronic heart failure who use beta-blockers. BMC Cardiovascular Disorders. 23(1). 128–128. 3 indexed citations
13.
Lan, Tao-Hua, Wei Jiang, Tong Liu, et al.. (2022). Metabolism disorder promotes isoproterenol-induced myocardial injury in mice with high temperature and high humidity and high-fat diet. BMC Cardiovascular Disorders. 22(1). 133–133. 16 indexed citations
14.
Lan, Tao-Hua, et al.. (2022). Nontargeted Metabolomic Profiling of Huo-Tan-Chu-Shi Decoction in the Treatment of Coronary Heart Disease with Phlegm-damp Syndrome. Cardiology Research and Practice. 2022. 1–11. 3 indexed citations
15.
Lan, Tao-Hua, et al.. (2021). Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis. Chinese Journal of Integrative Medicine. 27(11). 867–873. 4 indexed citations
16.
Chen, Xiankun, Wei Jiang, Thomas P. Olson, et al.. (2021). Feasibility and Preliminary Effects of the BESMILE-HF Program on Chronic Heart Failure Patients: A Pilot Randomized Controlled Trial. Frontiers in Cardiovascular Medicine. 8. 715207–715207. 11 indexed citations
17.
Chen, Xiankun, Gaetano Marrone, Thomas P. Olson, et al.. (2020). Intensity Level and Cardiorespiratory Responses to Baduanjin Exercise in Patients with Chronic Heart Failure. ESC Heart Failure. 7(6). 3782–3791. 31 indexed citations
18.
Chen, Xiankun, Gianluigi Savarese, Cecilia Stålsby Lundborg, et al.. (2020). Tai Chi and Qigong Practices for Chronic Heart Failure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2020(1). 2034625–2034625. 15 indexed citations
19.
Zhang, Qunfang, Weihui Lu, Yuchao Chen, et al.. (2018). Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance. Frontiers in Immunology. 9. 2359–2359. 121 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chen Xia Breakdown of academic impact, for papers by Hui Yi Breakdown of academic impact, for papers by Takahiro Shirasawa Breakdown of academic impact, for papers by Yun‐Hong Cheon Breakdown of academic impact, for papers by Ewelina Józefczuk Breakdown of academic impact, for papers by Xueqing Li Breakdown of academic impact, for papers by Cleverson Rodrigues Fernandes Breakdown of academic impact, for papers by Layla Al-Mansoori Breakdown of academic impact, for papers by Min Cheng
Rankless by CCL
2026